Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $465.05 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oyster Point Pharma, Inc. | $156.35 | 3 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $121.30 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $61.75 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $44.36 | 2 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $33.98 | 1 | $0 (2024) |
| Dompe US, Inc. | $28.67 | 1 | $0 (2024) |
| Harrow Eye, LLC | $18.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.24 | 7 | Bausch & Lomb Americas Inc. ($44.36) |
| 2023 | $303.81 | 4 | Oyster Point Pharma, Inc. ($142.75) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: OPTOMETRY | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Dry eyes | ||||||
| 02/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $121.30 | General |
| Category: Ophthalmology | ||||||
| 08/09/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: DRY EYE | ||||||
| 05/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $122.01 | General |
| Category: DRY EYE | ||||||
About Dr. James Andrews, OD
Dr. James Andrews, OD is a Optometrist healthcare provider based in Athol, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2023. The National Provider Identifier (NPI) number assigned to this provider is 1518647379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Andrews, OD has received a total of $465.05 in payments from pharmaceutical and medical device companies, with $161.24 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($465.05).
Practice Information
- Specialty Optometrist
- Location Athol, MA
- Active Since 07/18/2023
- Last Updated 07/18/2023
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1518647379
Products in Payments
- TYRVAYA (Drug) $156.35
- Cequa (Drug) $121.30
- ACTHAR (Biological) $61.75
- XDEMVY (Drug) $33.98
- OXERVATE (Drug) $28.67
- MIEBO (Drug) $24.98
- enVista MX60 IOL (Device) $19.38
- VEVYE (Drug) $18.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.